Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

MDWD

MediWound Ltd

Apr 17 • 04:00PM ET

17.44

Dollar change -0.84
Percentage change -4.60	%

Healthcare • Biotechnology • Israel • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: IWC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.77	Insider Own	28.24%	Shs Outstand	9.22M	Perf Week	14.14%
Market Cap	165.51M	Forward P/E	-	EPS next Y	-1.86	Insider Trans	0.00%	Shs Float	6.81M	Perf Month	10.87%
Income	-6.72M	PEG	-	EPS next Q	-0.41	Inst Own	27.18%	Short Float	2.39%	Perf Quarter	34.67%
Sales	18.69M	P/S	8.86	EPS this Y	-157.33%	Inst Trans	-	Short Ratio	2.33	Perf Half Y	98.18%
Book/sh	3.43	P/B	5.09	EPS next Y	3.63%	ROA	-11.53%	Short Interest	0.16M	Perf Year	37.87%
Cash/sh	4.40	P/C	3.97	EPS next 5Y	-	ROE	-31.60%	52W Range	7.10 - 18.66	Perf YTD	71.48%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-22.25%	ROI	-17.70%	52W High	-6.55%	Beta	0.83
Dividend TTM	-	Quick Ratio	4.33	Sales past 5Y	158.87%	Gross Margin	19.15%	52W Low	145.63%	ATR (14)	1.08
Dividend Ex-Date	-	Current Ratio	4.59	EPS Y/Y TTM	80.05%	Oper. Margin	-82.96%	RSI (14)	63.62	Volatility	9.59% 6.81%
Employees	100	Debt/Eq	0.21	Sales Y/Y TTM	-29.48%	Profit Margin	-35.94%	Recom	1.00	Target Price	28.50
Option/Short	Yes / Yes	LT Debt/Eq	0.20	EPS Q/Q	83.95%	Payout	-	Rel Volume	2.24	Prev Close	18.28
Sales Surprise	0.17%	EPS Surprise	27.62%	Sales Q/Q	-54.05%	Earnings	Mar 21 BMO	Avg Volume	69.94K	Price	17.44
SMA20	12.56%	SMA50	19.11%	SMA200	60.26%	Trades		Volume	156,460	Change	-4.60%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-22-22	Initiated	Maxim Group	Buy	$11
Jul-18-22	Resumed	Oppenheimer	Outperform	$7
Sep-23-20	Initiated	BTIG Research	Buy	$6
Nov-28-16	Initiated	Aegis Capital	Buy	$11
Aug-17-16	Initiated	Wells Fargo	Outperform
Apr-16-14	Initiated	Oppenheimer	Outperform	$25

Today 07:24AM	Strength Seen in MediWound (MDWD): Can Its 14.3% Jump Turn into More Strength? (Zacks)
Mar-25-24 09:55AM	Wall Street Analysts See a 76.89% Upside in MediWound (MDWD): Can the Stock Really Move This High? (Zacks)
08:50AM	What Makes MediWound (MDWD) a Good Fit for 'Trend Investing' (Zacks)
Mar-21-24 11:54AM	MDWD Stock Earnings: MediWound Beats EPS, Beats Revenue for Q4 2023 (InvestorPlace)
08:25AM	MediWound (MDWD) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
07:25AM	Loading…
07:25AM	MediWound: Q4 Earnings Snapshot (Associated Press Finance)
07:00AM	MediWound Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update (GlobeNewswire)
Mar-14-24 08:00AM	MediWound to Report Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Mar-06-24 08:46AM	MediWound (MDWD) Moves 7.1% Higher: Will This Strength Last? (Zacks) +7.52%
Feb-12-24 07:00AM	MediWound Announces Positive Results in Head-to-Head Comparison of EscharEx vs. SANTYL within the ChronEx Phase II Randomized Controlled Study (GlobeNewswire)
Feb-05-24 08:00AM	MediWound to Participate in Two Upcoming Investor Conferences (GlobeNewswire) -8.69%
Jan-15-24 09:55AM	MediWound (MDWD)'s Technical Outlook is Bright After Key Golden Cross (Zacks)
Jan-09-24 06:21PM	Wall Street Analysts Think MediWound (MDWD) Could Surge 134.77%: Read This Before Placing a Bet (Zacks) +5.67%
08:48AM	MediWound (MDWD): Strong Industry, Solid Earnings Estimate Revisions (Zacks)
07:00AM	MediWound Announces that FDA has Accepted for Review the Supplement to the NexoBrid BLA to Include Pediatric Patients with Severe Thermal Burns (GlobeNewswire)
07:00AM	Loading…
Dec-28-23 07:00AM	MediWound Secures Additional U.S. Department of Defense Funding to Advance NexoBrid Development for the U.S. Army (GlobeNewswire)
Dec-21-23 08:00AM	MediWound Announces Peer-Reviewed Publication of EscharEx Mechanism of Action Study Assessing Its Effects on Biofilm and Microbial Loads (GlobeNewswire)
Dec-13-23 09:55AM	Wall Street Analysts Believe MediWound (MDWD) Could Rally 171.79%: Here's is How to Trade (Zacks)
Nov-27-23 09:55AM	Does MediWound (MDWD) Have the Potential to Rally 223.05% as Wall Street Analysts Expect? (Zacks)
Nov-21-23 07:12AM	MediWound: Q3 Earnings Snapshot (Associated Press Finance)
07:02AM	MediWound Reports Third Quarter 2023 Financial Results and Provides Company Update (GlobeNewswire)
07:00AM	MediWound Announces Appointment of Shmulik Hess, Ph.D. as Chief Operating Officer and Chief Commercial Officer (GlobeNewswire)
Nov-14-23 08:02AM	MediWound to Report Third Quarter 2023 Financial Results (GlobeNewswire)
Nov-13-23 07:00AM	MediWound Receives Positive CHMP Opinion Recommending Approval for NexoBrid to Treat Pediatric Patients (GlobeNewswire)
Nov-08-23 07:00AM	MediWound Announces a Collaboration with PolyMedics Innovations (PMI) for NexoBrid Distribution in Europe (GlobeNewswire)
Oct-11-23 06:00AM	MediWound Announces Collaboration with 3M on EscharEx Phase III Study (GlobeNewswire)
Oct-09-23 07:34AM	MediWound Deploys NexoBrid for Emergency Supply (GlobeNewswire)
Oct-03-23 01:20PM	Q4 Stock Predictions: 3 Micro-Cap Stocks Ready to Skyrocket Into 2024 (InvestorPlace)
Sep-29-23 08:00AM	MediWound (MDWD) Surges 18.2%: Is This an Indication of Further Gains? (Zacks)
Sep-26-23 07:00AM	MediWound Secures Additional U.S. Department of Defense Funding to Advance NexoBrid® Development for the U.S. Army (GlobeNewswire)
06:00AM	Loading…
Sep-21-23 06:00AM	MediWound Announces U.S. Commercial Availability of NexoBrid® for the Treatment of Severe Thermal Burns in Adults (GlobeNewswire)
Sep-11-23 08:00AM	MediWounds NexoBrid® Highlighted in 20 Oral and Poster Presentations at the 20th European Burns Association Congress (GlobeNewswire) +6.82%
Sep-05-23 08:00AM	MediWound to Participate in Fireside Chat at H.C. Wainwright 25th Annual Global Investment Conference (GlobeNewswire)
Aug-15-23 05:15PM	MediWound (MDWD) Q2 Earnings and Revenues Beat Estimates (Zacks)
04:11PM	MediWound: Q2 Earnings Snapshot (AP Finance)
04:03PM	MediWound Reports Second Quarter 2023 Financial Results and Provides Company Update (GlobeNewswire)
04:02PM	MediWound Announces Collaboration with Mölnlycke on EscharEx® Phase III Study (GlobeNewswire)
04:01PM	MediWound Announces Collaboration with MIMEDX on EscharEx® Phase III Study (GlobeNewswire)
Aug-07-23 08:00AM	MediWound to Report Second Quarter 2023 Financial Results (GlobeNewswire)
Aug-01-23 07:30AM	MediWound Announces Commercial Launch of NexoBrid® in Japan (GlobeNewswire)
Jul-11-23 06:05AM	3 Micro-Cap Stocks to Buy for Multibagger Returns (InvestorPlace)
Jul-10-23 07:30AM	MediWound Announces Positive Results in Its U.S. Phase I/II Study of MW005 for the Treatment of Basal Cell Carcinoma (GlobeNewswire)
Jul-03-23 07:00AM	MediWound Receives Positive Scientific Advice from European Medicine Agency (EMA) on EscharEx Phase III Study Design (GlobeNewswire)
Jun-28-23 06:51AM	MediWound (NASDAQ:MDWD) shareholders have endured a 79% loss from investing in the stock five years ago (Simply Wall St.)
Jun-14-23 08:00AM	MediWound to Participate in Fireside Chat at Maxim Group Healthcare Virtual Conference 2023 (GlobeNewswire)
Jun-01-23 06:07AM	Analyst Forecasts Just Became More Bearish On MediWound Ltd. (NASDAQ:MDWD) (Simply Wall St.)
May-30-23 08:15AM	MediWound (MDWD) Reports Q1 Loss, Misses Revenue Estimates (Zacks) -7.46%
07:08AM	MediWound: Q1 Earnings Snapshot (AP Finance)
07:00AM	MediWound Reports First Quarter 2023 Financial Results and Provides a Company Update (GlobeNewswire)
May-12-23 08:00AM	MediWound to Report First Quarter 2023 Financial Results (GlobeNewswire)
May-09-23 07:30AM	MediWound Announces an Additional $10 Million Award from BARDA (GlobeNewswire)
Apr-26-23 08:00AM	MediWound to Present Phase 2 EscharEx® Data at the Symposium on Advanced Wound Care (SAWC) Spring 2023 (GlobeNewswire)
Apr-19-23 11:40AM	Pinning Down MediWound Ltd.'s (NASDAQ:MDWD) P/S Is Difficult Right Now (Simply Wall St.)
Mar-18-23 08:26AM	We Think MediWound (NASDAQ:MDWD) Can Afford To Drive Business Growth (Simply Wall St.)
08:22AM	MediWound Full Year 2022 Earnings: Revenues Beat Expectations, EPS Lags (Simply Wall St.)
Mar-16-23 08:35AM	MediWound (MDWD) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
07:10AM	MediWound Reports Fourth Quarter and Full Year 2022 Financial Results and Company Update (GlobeNewswire)
07:00AM	MediWound Announces the Appointment of Hani Luxenburg as Chief Financial Officer (GlobeNewswire)
Mar-09-23 10:00AM	MediWound (MDWD) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks)
Mar-06-23 07:00AM	MediWound Expands its Global Leadership Team to Help Drive Companys Future Growth (GlobeNewswire)
Mar-02-23 08:47AM	MediWound to Report Fourth Quarter and Year-End 2022 Financial Results (GlobeNewswire)
Feb-23-23 08:00AM	MediWound to Present Corporate Highlights at Upcoming Investor Conferences (GlobeNewswire)
Feb-16-23 05:31AM	Institutions own 29% of MediWound Ltd. (NASDAQ:MDWD) shares but individual investors control 43% of the company (Simply Wall St.)
Feb-07-23 04:01PM	MediWound Announces Closing of $27.5 Million Registered Direct Offering of Ordinary Shares (GlobeNewswire)
Feb-03-23 10:30AM	MediWound Announces $27.5 Million Registered Direct Offering of Ordinary Shares Priced At-The-Market (GlobeNewswire)
Jan-13-23 10:19AM	Buy These 2 Stocks Before They Jump Over 80%, Say Analysts (TipRanks) +5.20%
Jan-06-23 07:19AM	MediWound (NASDAQ:MDWD) investors are sitting on a loss of 61% if they invested five years ago (Simply Wall St.)
Dec-30-22 05:26AM	FDA Approves MediWound's NexoBrid For Burn Treatment (Benzinga)
Dec-29-22 01:46PM	MediWound Announces FDA Approval of NexoBrid® for the Treatment of Severe Thermal Burns in Adults (GlobeNewswire)
Dec-23-22 08:00AM	MediWound Expands NexoBrids Global Presence with Marketing Approval in Japan (GlobeNewswire) +5.02%
Dec-20-22 08:00AM	MediWound Strengthens European Presence of NexoBrid® (GlobeNewswire) +17.70%
Dec-19-22 07:00AM	MediWound Announces Positive Results in U.S. Phase I/II Study of MW005 for the Treatment of Basal Cell Carcinoma (GlobeNewswire) -7.59%
Dec-13-22 05:30AM	MediWound Expands Global Presence as NexoBrid® Gains Approval in India (GlobeNewswire)
Dec-05-22 04:05PM	MediWound Announces a 1-for-7 Reverse Share Split (GlobeNewswire) -5.77%
Nov-15-22 08:15AM	MediWound (MDWD) Reports Q3 Loss, Tops Revenue Estimates (Zacks) +15.17%
07:00AM	MediWound Reports Third Quarter 2022 Financial Results and Provides Company Update (GlobeNewswire)
Nov-09-22 08:00AM	MediWounds EscharEx Featured in Paper as a Potential Paradigm Shift Towards Non-Surgical Wound Bed Preparation in DFUs (GlobeNewswire) -6.43%
Nov-03-22 08:00AM	MediWound to Report Third Quarter 2022 Financial Results (GlobeNewswire)
Oct-25-22 07:00AM	MediWound Announces Formation of Strategic Advisory Board (GlobeNewswire)
Oct-18-22 07:00AM	MediWound's EscharEx® Featured in Oral and Poster Presentations at the Symposium on Advanced Wound Care (SAWC) Fall 2022 (GlobeNewswire) +10.69%
Oct-07-22 06:00AM	MediWound Announces Closing of the Concurrent Registered Direct and Private Placement Offerings (GlobeNewswire)
Sep-22-22 08:02AM	MediWound Announces Concurrent Registered Direct and Private Placement Offerings Priced At-the-Market of Approximately $30 Million (GlobeNewswire) -22.86%
Sep-20-22 07:00AM	EMA Accepts MediWounds Application for Extended Indication for NexoBrid to Treat Pediatric Patients with Severe Thermal Burns (GlobeNewswire)
Sep-12-22 08:00AM	MediWounds NexoBrid® Highlighted in 45 Posters and Presentations at the 19th European Burns Association Congress (GlobeNewswire)
Aug-23-22 07:00AM	IsoPlexis Announces the Appointment of former Luminex Corporation Chairman and CEO, Nachum Homi Shamir to its Board of Directors (GlobeNewswire)
Aug-15-22 06:08AM	Things Look Grim For MediWound Ltd. (NASDAQ:MDWD) After Today's Downgrade (Simply Wall St.) +5.71%
Aug-09-22 08:45AM	MediWound (MDWD) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
07:30AM	MediWound Reports Second Quarter 2022 Financial Results and Provides Company Updates (GlobeNewswire)
Aug-08-22 04:05PM	MediWound Enhances Its Board and Executive Leadership Team (GlobeNewswire)
Aug-03-22 07:30AM	MediWound Announces U.S. FDA Acceptance of Biologics License Application for NexoBrid for the Treatment of Severe Thermal Burns (GlobeNewswire)
Aug-02-22 10:00AM	MediWound (MDWD) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks)
Aug-01-22 08:00AM	MediWound Schedules Second Quarter 2022 Financial Results (GlobeNewswire)
Jul-11-22 11:12AM	MediWound Posts Early Data From Non-Melanoma Skin Cancer Trial (Benzinga)
07:00AM	MediWound Announces Positive Initial Data from its U.S. Phase I/II Study of MW005 for the Treatment of Basal Cell Carcinoma (GlobeNewswire)
Jul-08-22 08:00AM	MediWound Announces Presentation on EscharEx at the Advanced Wound Care Summit in Boston on July 13 (GlobeNewswire)
Jul-07-22 09:19AM	MediWound's EscharEx Shows Safe, Effective, Rapid Debridement Of Leg Ulcers (Benzinga)
07:00AM	MediWound Announces Positive Results from its U.S. Phase 2 Pharmacology Study of EscharEx for Debridement of Lower Leg Ulcers (GlobeNewswire)
Jul-05-22 04:05PM	MediWound to Host a Key Opinion Leader Investor Day on EscharEx (GlobeNewswire)
Jul-04-22 03:01PM	MediWound (NASDAQ:MDWD) shareholders are up 13% this past week, but still in the red over the last five years (Simply Wall St.)
Jun-30-22 07:00AM	MediWound Names Mr. Tzvi Palash as Chief Operating Officer (GlobeNewswire)

MediWound Ltd. is a biopharmaceutical company, which engages in the development, manufacture, and commercialization of products to address needs in the fields of severe burns, chronic wounds, and other hard-to-heal wounds. Its product NexoBrid, is an orphan biologic for eschar removal in severe burns. The company was founded by Lior Rosenberg and Marian Gorecki in January 2000 and is headquartered in Yavne, Israel.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

MDWD

MediWound Ltd

Upgrade your FINVIZ experience